Literature DB >> 36094482

Brief Report: Undercarboxylated Osteocalcin Is Associated With Cognition in Women With and Without HIV.

Ryan D Ross1, Arnold Z Olali1, Qiuhu Shi2, Donald R Hoover3, Anjali Sharma4, Kathleen M Weber5, Audrey L French6, Heather McKay7, Phyllis C Tien8, Michael T Yin9, Leah H Rubin10.   

Abstract

INTRODUCTION: Bone loss and cognitive impairment are common in women living with HIV (WLWH) and are exacerbated by menopause. Bone-derived undercarboxylated osteocalcin (ucOCN) and sclerostin appear to influence cognition. The current study investigated whether the circulating levels of these 2 proteins are associated with cognition in midlife WLWH and demographically similar HIV seronegative women.
METHODS: Plasma samples from women enrolled in a musculoskeletal substudy within the Women's Interagency HIV Study were used to measure ucOCN and sclerostin. A neuropsychological (NP) test battery assessing executive function, processing speed, attention/working memory, learning, memory, verbal fluency, and motor function was administered within 6 months of musculoskeletal enrollment and every 2 years after (1-4 follow-up visits per participant). A series of generalized estimating equations were conducted to examine the association between biomarkers and NP performance at the initial assessment and over time in the total sample and in WLWH only. Primary predictors included biomarkers, time, and biomarker by time interactions. If the interaction terms were not significant, models were re-run without interactions.
RESULTS: Neither biomarker predicted changes in NP performance over time in the total sample or in WLWH. ucOCN was positively associated with executive function in the total sample and in WLWH and with motor skills in WLWH. ucOCN was negatively associated with attention/working memory in the total sample. There were no significant associations between sclerostin and NP performance.
CONCLUSION: The current study suggests an association between bone-derived ucOCN and cognition in women with and without HIV infection.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 36094482      PMCID: PMC9470989          DOI: 10.1097/QAI.0000000000003043

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.771


  55 in total

1.  The Menopause Transition and Cognition.

Authors:  Gail A Greendale; Arun S Karlamangla; Pauline M Maki
Journal:  JAMA       Date:  2020-03-12       Impact factor: 56.272

2.  Antiretroviral Therapy Containing HIV Protease Inhibitors Enhances Fracture Risk by Impairing Osteoblast Differentiation and Bone Quality.

Authors:  Hiroyuki Hirakawa; Hiroyuki Gatanaga; Hiroki Ochi; Toru Fukuda; Satoko Sunamura; Shinichi Oka; Shu Takeda; Shingo Sato
Journal:  J Infect Dis       Date:  2017-06-15       Impact factor: 5.226

3.  The Protective Effects of Osteocyte-Derived Extracellular Vesicles Against Alzheimer's Disease Diminished with Aging.

Authors:  Ya-Ling Jiang; Zhen-Xing Wang; Xi-Xi Liu; Mei-Dan Wan; Yi-Wei Liu; Bin Jiao; Xin-Xin Liao; Zhong-Wei Luo; Yi-Yi Wang; Chun-Gu Hong; Yi-Juan Tan; Ling Weng; Ya-Fang Zhou; Shan-Shan Rao; Jia Cao; Zheng-Zhao Liu; Teng-Fei Wan; Yuan Zhu; Hui Xie; Lu Shen
Journal:  Adv Sci (Weinh)       Date:  2022-05-04       Impact factor: 17.521

4.  Bone loss predicts subsequent cognitive decline in older women: the study of osteoporotic fractures.

Authors:  Li-Yung Lui; Katie Stone; Jane A Cauley; Teresa Hillier; Kristine Yaffe
Journal:  J Am Geriatr Soc       Date:  2003-01       Impact factor: 5.562

5.  Patterns of osteocalcin and bone specific alkaline phosphatase by age, gender, and race or ethnicity.

Authors:  C M Gundberg; A C Looker; S D Nieman; M S Calvo
Journal:  Bone       Date:  2002-12       Impact factor: 4.398

6.  Lower serum osteocalcin concentrations are associated with brain microstructural changes and worse cognitive performance.

Authors:  Josep Puig; Gerard Blasco; Josep Daunis-i-Estadella; María Moreno; Xavier Molina; Angel Alberich-Bayarri; Gemma Xifra; Salvador Pedraza; Wifredo Ricart; Fernando Fernández-Aranda; José Manuel Fernández-Real
Journal:  Clin Endocrinol (Oxf)       Date:  2015-12-14       Impact factor: 3.478

7.  Increased risk of dementia in patients with osteoporosis: a population-based retrospective cohort analysis.

Authors:  Kuang-Hsi Chang; Chi-Jung Chung; Cheng-Li Lin; Fung-Chang Sung; Trong-Neng Wu; Chia-Hung Kao
Journal:  Age (Dordr)       Date:  2013-12-18

8.  Osteopenia and osteoporosis in patients with HIV: a review of current concepts.

Authors:  Todd T Brown; Grace A McComsey
Journal:  Curr Infect Dis Rep       Date:  2006-03       Impact factor: 3.725

Review 9.  Primary osteoporosis in postmenopausal women.

Authors:  Meng-Xia Ji; Qi Yu
Journal:  Chronic Dis Transl Med       Date:  2015-03-21

10.  Circulating sclerostin is associated with bone mineral density independent of HIV-serostatus.

Authors:  Ryan D Ross; Anjali Sharma; Qiuhu Shi; Donald R Hoover; Kathleen M Weber; Phyllis C Tien; Audrey L French; Lena Al-Harthi; Michael T Yin
Journal:  Bone Rep       Date:  2020-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.